MAPK14 (p38α) is a stress-activated protein kinase that plays critical roles in cellular stress response and disease pathogenesis. The protein functions as a key mediator in stress signaling pathways, becoming activated in response to ribosome collisions during translational stress through the upstream kinase ZAK 1. MAPK14 exhibits diverse biological functions including regulation of cell fate decisions, with inhibition leading to uncontrolled mitotic entry through Cdc25 activation and Wee1 blocking, ultimately triggering mitotic catastrophe in cancer cells 2. The kinase demonstrates significant disease relevance across multiple conditions. In prolactinoma, MAPK14 expression is elevated and promotes tumor development, with knockout studies showing reduced prolactin production and tumor growth 3. In endometrial cancer, MAPK14 shapes the molecular landscape of high-grade tumors and promotes tumorigenic characteristics, particularly in 3D spheroid cultures that model malignant disease 4. Additionally, genetic variants in MAPK14 show associations with spondyloarthritis through family-based genome-wide association studies 5 and contribute to brain volume deficits in schizophrenia patients with marijuana misuse through interactions with cannabinoid receptor genes 6. These findings establish MAPK14 as a versatile kinase with therapeutic potential across inflammatory, neurological, and oncological conditions 7.